Rapid Therapeutic Science Stock Analysis
| RTSL Stock | USD 0 0.00 0.00% |
Rapid Therapeutic Science is fairly valued with Real Value of 9.6E-4 and Hype Value of 6.87E-4. The main objective of Rapid Therapeutic pink sheet analysis is to determine its intrinsic value, which is an estimate of what Rapid Therapeutic Science is worth, separate from its market price. There are two main types of Rapid Therapeutic's stock analysis: fundamental analysis and technical analysis.
The Rapid Therapeutic pink sheet is traded in the USA on PINK Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA.
Rapid |
Rapid Pink Sheet Analysis Notes
About 66.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 0.51. Rapid Therapeutic Science had not issued any dividends in recent years. The entity had 1:25 split on the 31st of March 2022. Rapid Therapeutic Science Laboratories, Inc. operates as a biotech company. Rapid Therapeutic Science Laboratories, Inc. was a former subsidiary of Texas Mdi, Inc. Rapid Therapeutic operates under Medical Devices classification in the United States and is traded on OTC Exchange. It employs 8 people.The quote for Rapid Therapeutic Science is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. To find out more about Rapid Therapeutic Science contact Donal Schmidt at 800 497 6059 or learn more at https://www.rtslco.com.Rapid Therapeutic Science Investment Alerts
| Rapid Therapeutic is way too risky over 90 days horizon | |
| Rapid Therapeutic has some characteristics of a very speculative penny stock | |
| Rapid Therapeutic appears to be risky and price may revert if volatility continues | |
| Rapid Therapeutic Science currently holds 150 K in liabilities with Debt to Equity (D/E) ratio of 1.13, which is about average as compared to similar companies. Rapid Therapeutic Science has a current ratio of 0.07, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Rapid Therapeutic until it has trouble settling it off, either with new capital or with free cash flow. So, Rapid Therapeutic's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Rapid Therapeutic Science sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Rapid to invest in growth at high rates of return. When we think about Rapid Therapeutic's use of debt, we should always consider it together with cash and equity. | |
| The entity reported the previous year's revenue of 534. Net Loss for the year was (2.87 M) with profit before overhead, payroll, taxes, and interest of 334. | |
| Rapid Therapeutic Science currently holds about 112.16 K in cash with (2.21 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 66.0% of Rapid Therapeutic outstanding shares are owned by corporate insiders |
Rapid Market Capitalization
The company currently falls under 'Nano-Cap' category with a current market capitalization of 4.22 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Rapid Therapeutic's market, we take the total number of its shares issued and multiply it by Rapid Therapeutic's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Technical Drivers
As of the 26th of November, Rapid Therapeutic holds the Risk Adjusted Performance of 0.0767, coefficient of variation of 1144.39, and Variance of 589.28. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Rapid Therapeutic, as well as the relationship between them. Please check Rapid Therapeutic Science market risk adjusted performance and total risk alpha to decide if Rapid Therapeutic Science is priced some-what accurately, providing market reflects its current price of 0.001 per share. As Rapid Therapeutic Science appears to be a penny stock we also advise to check out its information ratio numbers.Rapid Therapeutic Science Price Movement Analysis
The output start index for this execution was eleven with a total number of output elements of fifty. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Rapid Therapeutic middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Rapid Therapeutic Science. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Rapid Therapeutic Outstanding Bonds
Rapid Therapeutic issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Rapid Therapeutic Science uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Rapid bonds can be classified according to their maturity, which is the date when Rapid Therapeutic Science has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| HSBC Holdings PLC Corp BondUS404280DR76 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View | |
| AerCap Global Aviation Corp BondUS00773HAA59 | View |
Rapid Therapeutic Predictive Daily Indicators
Rapid Therapeutic intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Rapid Therapeutic pink sheet daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Rapid Therapeutic Forecast Models
Rapid Therapeutic's time-series forecasting models are one of many Rapid Therapeutic's pink sheet analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Rapid Therapeutic's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Rapid Pink Sheet Analysis
Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how Rapid Therapeutic prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Rapid shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as Rapid Therapeutic. By using and applying Rapid Pink Sheet analysis, traders can create a robust methodology for identifying Rapid entry and exit points for their positions.
Rapid Therapeutic Science Laboratories, Inc. operates as a biotech company. Rapid Therapeutic Science Laboratories, Inc. was a former subsidiary of Texas Mdi, Inc. Rapid Therapeutic operates under Medical Devices classification in the United States and is traded on OTC Exchange. It employs 8 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our pink sheet analysis tools, you can find out how much better you can do when adding Rapid Therapeutic to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Idea Analyzer Now
Idea AnalyzerAnalyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |
| All Next | Launch Module |
Other Information on Investing in Rapid Pink Sheet
Rapid Therapeutic financial ratios help investors to determine whether Rapid Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Rapid with respect to the benefits of owning Rapid Therapeutic security.